Mireia Morgades de la Fe

9PUBLICATIONS
102CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersHaematological tumoursMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 28, 2026
Comprehensive genetic characterization of adult BCR::ABL1-negative B-ALL by Optical Genome Mapping and Targeted NGS.

|Jul 30, 2026
ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

|May 04, 2026
Genetics and MRD for therapy allocation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia.

|Jan 08, 2025
Preferential Genetic Pathways Lead to Relapses in Adult B-Cell Acute Lymphoblastic Leukemia.

Josgrey Navas-Acosta, Alberto Hernández-Sánchez, Teresa González

|Dec 17, 2024
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA Groups.

Susana Vives, David Quintela, Mireia Morgades

|Dec 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative study.

Amir Enshaei, Melvin Joy, Ellie Butler

Pageof 2

Frequent Collaborators

7 joint publications

Josep-Maria Ribera Santasusana

4 joint publications

Jesús-María Hernández-Rivas

3 joint publications

Ricardo Sánchez

3 joint publications

Alberto Orfao